3/20
04:37 pm
antx
Form 8-K AN2 Therapeutics, Inc. For: Mar 19
Low
Report
Form 8-K AN2 Therapeutics, Inc. For: Mar 19
3/17
04:10 pm
antx
Form S-8 AN2 Therapeutics, Inc.
Medium
Report
Form S-8 AN2 Therapeutics, Inc.
3/17
04:04 pm
antx
Form 10-K AN2 Therapeutics, Inc. For: Dec 31
Medium
Report
Form 10-K AN2 Therapeutics, Inc. For: Dec 31
3/17
04:02 pm
antx
Form 8-K AN2 Therapeutics, Inc. For: Mar 17
Medium
Report
Form 8-K AN2 Therapeutics, Inc. For: Mar 17
3/16
04:21 pm
antx
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: Commodore Capital LP
Medium
Report
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: Commodore Capital LP
3/13
05:02 pm
antx
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: INTEGRATED CORE STRATEGIES (US) LLC
Medium
Report
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: INTEGRATED CORE STRATEGIES (US) LLC
3/13
04:02 pm
antx
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: Vivo Opportunity Fund Holdings, L.P.
Medium
Report
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: Vivo Opportunity Fund Holdings, L.P.
3/10
06:03 am
antx
Form 8-K AN2 Therapeutics, Inc. For: Mar 08
High
Report
Form 8-K AN2 Therapeutics, Inc. For: Mar 08
3/5
06:55 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 03 Filed by: Williams Sarah Joanne
High
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 03 Filed by: Williams Sarah Joanne
2/23
04:41 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Eizen Joshua M
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Eizen Joshua M
2/23
04:41 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Day Lucy
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Day Lucy
2/23
04:40 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Williams Sarah Joanne
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Williams Sarah Joanne
2/23
04:37 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Easom Eric
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Easom Eric
2/23
04:35 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Chanda Sanjay
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Chanda Sanjay
2/23
04:30 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Marks Gilbert Lynn
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Marks Gilbert Lynn
2/23
04:29 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Readnour Robin Shane
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Readnour Robin Shane
2/23
04:28 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Wong Stephanie
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Wong Stephanie
2/23
04:24 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Martin Patricia A.
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Martin Patricia A.
2/23
04:22 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Spigelman Melvin K
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Spigelman Melvin K
2/23
04:21 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Aziz Kabeer
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Aziz Kabeer
2/23
04:17 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: FitzPatrick Margaret M
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: FitzPatrick Margaret M
2/23
04:11 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Zakrzewski Joseph S
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Zakrzewski Joseph S
2/17
06:54 pm
antx
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: Almitas Capital LLC
Low
Report
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: Almitas Capital LLC
2/13
04:31 pm
antx
Form SCHEDULE 13G/A AN2 Therapeutics, Inc. Filed by: Easom Eric
Low
Report
Form SCHEDULE 13G/A AN2 Therapeutics, Inc. Filed by: Easom Eric
2/3
06:09 pm
antx
Form 3 AN2 Therapeutics, Inc. For: Jan 26 Filed by: Williams Sarah Joanne
Low
Report
Form 3 AN2 Therapeutics, Inc. For: Jan 26 Filed by: Williams Sarah Joanne